Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-060456·Innate Pharma SA
Schedule 13G ownership disclosure
Innate Pharma SA
Ordinary Shares, Euro 0.05 nominal value per share · CUSIP: 45781K105
Event date: 2025-04-23
- Filing-level shares
- 8,345,387
- Percent of class
- 9.05%
- SANOFI
Shares: 8,345,387 · Class: 9.05%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-060456
- Form type
- SCHEDULE 13G/A
- Filer
- Innate Pharma SA
- CIK
- CIK 1598599
- Filed
- Apr 29, 2025
- Reporting period
- Apr 23, 2025
- Description
- Schedule 13G beneficial ownership